Fresh Frozen Plasma in Trauma with Liver Hematoma: Not Routinely Necessary
Fresh frozen plasma (FFP) should NOT be administered to a trauma patient with a liver hematoma unless there is evidence of active major hemorrhage with coagulopathy or hemodynamic instability requiring massive transfusion. 1
Clinical Decision Algorithm
1. Assess Hemodynamic Status First
- Hemodynamically stable patient with liver hematoma: FFP is NOT indicated 1
- Hemodynamically unstable with active bleeding: Consider FFP as part of major hemorrhage protocol 1, 2
2. Evaluate for Active Bleeding
The critical distinction is whether the patient has:
- Contained hematoma without active bleeding: No FFP needed
- Active hemorrhage requiring transfusion: FFP may be indicated in specific ratios 1
3. Check Coagulation Status
FFP is only indicated when:
- PT/INR > 1.5 times normal AND active bleeding 3, 4
- Major hemorrhage protocol activated with anticipated massive transfusion (>1 blood volume) 1
- Coagulation tests show established coagulopathy (PT/aPTT > 1.5 times normal) with ongoing bleeding 2
FFP is NOT indicated when:
- Coagulation tests are normal or mildly abnormal without bleeding 1
- Patient is hemodynamically stable 1, 3
- Used solely for volume replacement 1
Key Evidence and Rationale
The most recent 2025 Association of Anaesthetists guidelines explicitly state that abnormal standard coagulation tests (PT, APTT) are poor predictors of bleeding in critically ill and hemodynamically stable patients 1. This is particularly relevant for liver injuries, as the guideline specifically notes these tests "do not reflect the true haemostatic status of patients with advanced liver disease" 1.
Major Hemorrhage Context
If the patient progresses to major hemorrhage, FFP should be administered in a 1:1 or 1:1.5 ratio with red blood cells until coagulation test results are available 1. The 2010 guidelines recommend early FFP infusion (15 ml/kg) only when a senior clinician anticipates massive hemorrhage, with established coagulopathy requiring more aggressive replacement 2.
Dosing When Indicated
When FFP is necessary:
- Initial dose: 10-15 ml/kg to achieve minimum 30% plasma factor concentration 4
- In major hemorrhage: Administer in balanced ratios with RBCs (1:1 or 1:1.5) 1
- Donor and recipient blood groups should match; if unknown, use low-titre ABO non-identical plasma 1
Common Pitfalls to Avoid
Do not give prophylactic FFP to correct mildly abnormal coagulation tests before low-risk procedures in stable patients 1
Do not use FFP for volume replacement - this is explicitly contraindicated 1, 3, 1
Do not transfuse based solely on laboratory values without clinical evidence of bleeding 1, 5
Recognize that liver disease patients may have abnormal PT/INR that doesn't reflect actual bleeding risk due to "balanced hemostasis" 1, 3
Alternative Considerations
For a stable liver hematoma without active bleeding, management should focus on:
- Hemodynamic monitoring
- Serial imaging if clinically indicated
- Observation for signs of expansion or rupture
- Interventional radiology (embolization) if bleeding develops 6
The Surviving Sepsis Campaign guidelines reinforce that FFP should not be used to correct clotting abnormalities in the absence of bleeding or planned invasive procedures 5, which directly applies to a contained liver hematoma scenario.